EHA HIGHLIGHTS 2024 – LYMPHOMA ROUNDTABLE DISCUSSION: BGB-16673-101 STUDY
OR
Chair
Dr. Robert Kridel
Panelists
Dr. Kerry Savage
Dr. Diego Villa
This program has been made possible through unrestricted support from Roche.
Studies/trials discussed:
- Acalabrutinib plus Bendamustine and Rituximab in Untreated Mantle Cell Lymphoma: Results from the phase III Double Blind Placebo-controlled ECHO Trial
